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TCE (trichloroethylene, ClHC=CCl2), is a
man-made chlorinated hydrocarbon in a
ubiquitous class of pollutants used mainly as
a solvent and is considered an animal carcino-
gen and a potential health hazard to humans.
Halogenated hydrocarbons such as TCE and
dichloroethylene (DCE) are among the most
common water supply contaminants in the
United States and abroad (1). Some products
of these solvents are produced as a result of
chlorination of municipal water supplies that
contain natural organic material. TCE,
because of its wide use and thoughtless dis-
posal, is also a compound frequently detected
at monitored sites. Its associations with
adverse health effects have been studied, and
it is one of the targets of bioremediation.
The possible link between environmental
agents and human cardiac defects has long
been known (2). Trichloroethane, a com-
pound closely related to TCE, was investi-
gated for its possible correlation with human
congenital cardiac disease (3). Zierler et al.
(4) showed that workers exposed to solvents
experienced an associated increased preva-
lence of congenital heart disease. An epi-
demiology study by Goldberg et al. (5)
determined that the distribution of patients
with congenital heart disease in the Tucson,
Arizona, basin was associated with an area of
water supply contaminated with TCE, DCE,
and chromium. Contamination of those
drinking water supplies, which had probably
begun during the 1950s, was identified in
1981. After closure of the affected wells, the
incidence of congenital cardiac disease fell
dramatically in the contaminated area. This
sequence of events and later statistical assess-
ment established the higher prevalence of con-
genital heart disease in children whose parents
were exposed to the contaminated water com-
pared with children born to parents who were
never so exposed (5). The cardiac lesions
occurring in the area of contaminated water
supply varied and showed no signiﬁcant dif-
ference for lesion type when case and case
control values were compared, although a
cause-and-effect relationship could not
directly be established in the experimental
design.
Several other epidemiologic studies have
examined the reported association between
halogenated hydrocarbon contamination and
increased incidence of major congenital car-
diac malformations, other birth defects, and
birth outcomes (3,6–12). Considerable infor-
mation is available regarding the short- and
long-term toxicity of these agents and, to a
lesser extent, their general teratogenicity
(13–18). Recent research has implicated
halogenated hydrocarbons as speciﬁc cardiac
teratogens in animal models and has indi-
cated their signiﬁcance to health issues in the
United States and abroad (14,19–21).
Specific metabolites of TCE and DCE have
now been identiﬁed for their role in defective
cardiac development (22). These metabolites,
especially trichloroacetic acid (19,22,23),
have been discussed in detail by other
researchers, and a discussion of these ﬁndings
is beyond the scope of this article, particu-
larly because the data from Boyer et al. (24)
suggest that the cardiac valvular and septal
malformations may be caused by TCE’s
inhibiting endothelial separation and early
events of mesenchymal cell formation in the
developing heart.
The goal of this research was to determine
whether there was a threshold level of TCE in
drinking water above which the incidence of
congenital cardiac defects in the rodent
increased signiﬁcantly.
Methodology
All animals used in this study were main-
tained in a facility approved by the
Association for Assessment and Accreditation
of Laboratory Animal Care International and
in accordance with the established guidelines
of the University of Arizona’s Institutional
Animal Care and Use Committee, the
Animal Welfare Act, and U.S. Public Health
Service policy standards. They were given
access to food (4% rat diet; Teklad, Madison,
WI) and water ad libitum. Each animal was
identiﬁed individually by an ear notch code,
and they were housed in groups of three or
four, except for breeding males, which were
individually housed.
According to the same animal model as in
previous studies, various concentrations of
TCE were administered in drinking water to
pregnant Sprague-Dawley rats (5,19,21).
Once pregnant, the rats were randomly
placed in test groups. The animals were given
fresh drinking water that contained the
appropriate concentration of TCE ad libitum
during the entire pregnancy (22 days). The
test solutions were made daily to ensure the
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Halogenated hydrocarbons such as trichloroethylene (TCE) are among the most common water
supply contaminants in the United States and abroad. Epidemiologic studies have found an associ-
ation but not a cause-and-effect relation between halogenated hydrocarbon contamination and
increased incidence of congenital cardiac malformations or other defective birth outcomes. Avian
and rat studies demonstrated statistically signiﬁcant increases in the number of congenital cardiac
malformations in those treated with high doses of TCE, either via intrauterine pump or in mater-
nal drinking water, compared with controls. This study attempts to determine if there is a thresh-
old dose exposure to TCE above which the developing heart is more likely to be affected.
Sprague-Dawley rats were randomly placed in test groups and exposed to various concentrations
of TCE (2.5 ppb, 250 ppb, 1.5 ppm, 1,100 ppm) in drinking water or distilled water (control
group) throughout pregnancy. The percentage of abnormal hearts in the treated groups ranged
from 0 to 10.48%, with controls having 2.1% abnormal hearts, and the number of litters with
fetuses with abnormal hearts ranged from 0 to 66.7%, and the control percentage was 16.4%. The
data from this study indicate not only that there is a statistically signiﬁcant probability overall of a
dose response to increasing levels of TCE exposure, but also that this trend begins to manifest at
relatively low levels of exposure (i.e., < 250 ppb). Maternal rats exposed to more than this level of
TCE during pregnancy showed an associated increased incidence of cardiac malformations in their
developing rat fetuses. Key words: cardiac malformations, cardiac teratogenicity, environmental
contaminants, halogenated hydrocarbon, heart defects, heart development, TCE, trichloroethylene.
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Research | Articlesfreshness of the solution. This provided a
more consistent concentration in the solution
to compensate for the amount of hydrocar-
bon lost because of environmental exposure,
and allowed recording of amounts consumed
over a 24-hr period. Treatment groups were
distilled water controls, 2.5 ppb TCE
(0.00045 mg/kg), 250 ppb TCE (0.048
mg/kg), 1.5 ppm TCE (0.218 mg/kg), and
1,100 ppm TCE (128.52 mg/kg). The
amounts received by the rats per day were cal-
culated by the average of the breakdown of
TCE due to environmental exposure over a
24-hr period and the average amount of
drinking water consumed by each group. For
consistency and ease of reporting, we refer to
the levels by the initial concentration. The
groups tested are described in Table 1.
On the last day of pregnancy, each dam
was euthanized. Dams and fetuses were exam-
ined for gross organ abnormalities. Placement
of the fetuses, placental weights, and fetal
crown–rump length, sex, and weights were
recorded. The hearts and great vessels were
examined in situ for external gross malforma-
tions. The hearts were then removed, ﬂushed
with 10% formalin, and placed in 10% for-
malin solution for later dissection. Each heart
was given a code to comply with blind study
requirements.
A Nikon SMZ-2T light microscope with
television monitor (Nikon, Tempe, AZ) pro-
vided excellent visualization of the hearts for
individual dissection. Hearts were examined by
the strict protocol established for previous
studies by the investigators. The course, cal-
iber, and orientation of the aorta and pul-
monary vessels were determined. The atrial
appendages were removed and the atrial sep-
tum evaluated. After removal of the aorta, pul-
monary vessel, and atrial appendages, the
pulmonary, aortic, tricuspid, and mitral valves
were examined and probed for patency. The
formation of each leaﬂet was carefully evalu-
ated. The ventricular septum was then visual-
ized by removal of the left ventricular free wall.
Any suspected abnormality was held for later
observation by all three investigators. After
unanimous agreement on an abnormality, it
was photographed using a Nikon N2020 cam-
era mounted on the light microscope.
Two outcomes (frequency of abnormal
hearts in each group and frequency of litters
with at least one fetus with an abnormal
heart) were analyzed using a 5 × 2 chi-square
test of homogeneity. Because both overall
tests were statistically significant, pairwise
comparisons of treated groups with control
were made using 2 × 2 chi-square tests of
homogeneity. A probit analysis of the fre-
quency of abnormal hearts in each group was
done to identify the dose–response curve—
that is, the predicted probability of abnormal
hearts for a specified TCE concentration.
Probit analysis was performed with logit
transformation, and the natural response rate
was calculated from the rate seen in the 
control group.
Results
As shown in Tables 1 and 2, 98 dams and
1,146 fetuses were examined. Maternal and
fetal variables, including noncardiac congeni-
tal abnormalities, showed no significant dif-
ferences between treated and control groups.
In contrast, comparisons across groups of the
incidence of heart abnormalities showed that
there were significant differences between
groups, both in the incidence of abnormal
hearts per group [chi-squared (4) = 26.39,
p < 0.001] and in the incidence of litters with
one or more abnormal hearts [chi squared (4)
= 17.82, p = 0.001]. As shown in Figures 1
and 2, the control group had a 2% rate of
abnormal hearts and a 16% rate of litters with
at least one fetus with an abnormal heart.
This percentage is similar to that reported in
human studies and in rat studies using this
model (25). In comparison, rats exposed to
the highest dose of TCE (1,100 ppm) had a
10.5% rate of abnormal hearts and a 67%
rate of litters with one or more abnormal
hearts, rates significantly higher than in the
control group (p < 0.001). Intermediate
exposure levels produced intermediate
response rates. As shown in Figure 3, probit
analysis suggested that a concentration of
2,692 ppm (315 mg/kg dose) would be
required to produce abnormal hearts in 50%
of the fetuses (see Figure 3).
The variety of heart defects produced is
consistent with previous studies, including
those in the avian model, intrauterine mam-
malian exposure studies, and previous mater-
nal drinking water studies (19–21). The types
of defects found were as follows: absent coro-
nary artery, enlarged coronary artery sinus,
secundum-type atrial septal defects, aortic
valve defect with fused leaﬂets creating aortic
valvular stenosis, aortic valve defect with fen-
estrated leaflets, hypoplastic mitral valve
annulus, hypoplastic tricuspid valve annulus,
d-transposition, atrioventricular canal, and
both membranous (subaortic) and muscular
ventricular septal defects (Table 2). It is
important to note that no litters in the treated
or control groups had more than three abnor-
mal fetuses (one litter in control, one in 1.5
ppm, and two in 1,100 ppm groups had
three abnormal fetuses). All other litters had
one or two abnormal fetuses only. Of inter-
est, although not of individual statistical sig-
niﬁcance, is the fact that a similar percentage
of defects was found in the 250 ppb and 1.5
ppm studies. These values contributed to the
observed overall trend toward a dose-related
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Table 1. TCE test groups.
Initial Avg conc/24-hr Equivalent No. of Total no.
conc drinking water (ppb) avg dose (mg/kg) maternal rats of fetuses
1,100 ppm 918,500 129 9 105
1.5 ppm 1252.5 0.218 13 181
250 ppb 208.75 0.048 9 110
2.5 ppb 2.09 0.00045 12 144
Control 0 0 55 606
Abbreviations: Avg, average; conc, concentration.
Table 2. Types of heart malformations per 100 fetuses.
TCE dose group
Type of defect/100 fetuses Control 1,100 ppm 1.5 ppm 250 ppb 2.5 ppb
Abnormal looping 0.33 1
Coronary artery/sinus 1.82
Aortic hypoplasia 0.55
Pulmonary artery hypoplasia 0.55
Atrial septal defect 1.16 6.67 2.21 0.91
Mitral valve defect 0.17 0.91
Tricuspid valve defect 0.91
Ventricular septal defect
Perimembranous (subaortic) 0.33 2.86 1.66
Muscular 0.33 0.95 0.55
Atrioventricular septal defect 0.17 0.95
Pulmonary valve defect
Aortic valve defects 1.9 0.91
Fetuses with abnormal hearts (n)1 3 1 1 9 5 0
Total fetuses (n) 606 105 181 110 144
Litters with fetuses with
abnormal hearts/litters (n) 9/55 6/9 5/13 4/9 0/12
Litters with fetuses with
abnormal hearts/no. litters (%) 16.4 66.7 38.5 44.4 0.0
Data were calculated on a per-100 fetus basis (i.e., 7/6.06 = normalized number for atrial septal defect in control group =
1.16).effect and could indicate that a threshold
effect exists at a level between 1.5 and 1,100
ppm (21,22).
Discussion
It is known that TCE is capable of placental
transfer from mother to fetus (26). Small size
and lipid solubility permit TCE to easily
cross the placental barrier. Analysis of blood
taken simultaneously from both mother and
fetus has shown the presence of TCE in
maternal and fetal blood. These studies, done
in humans, found that the ratio of fetal con-
centration to maternal concentration of TCE
varied from one subject to another (26). This
has also been demonstrated in rodents admin-
istered TCE by gavage (27). Previous studies
have identiﬁed organogenesis as the most vul-
nerable period of exposure, and although the
experimental studies discussed here cannot be
extrapolated directly to humans, many
processes of cell division, migration, and dif-
ferentiation are common to all mammals dur-
ing fetal development.
TCE exposure in vitro, using a chick
model, has been shown to affect several 
elements of epithelial–mesenchymal cell
transformation. The endothelial cell–cell sep-
aration process that is associated with
endothelial activation was blocked by TCE.
TCE at concentrations ranging from 50 to
250 ppm also inhibited mesenchymal cell for-
mation. The expressions of the transcription
factors Mox-1 and extracellular matrix pro-
tein ﬁbrillin 2 were also inhibited (24). This
concentration range (50–25 ppm TCE) cor-
relates well with our ﬁndings (Figure 1).
As a consequence of its solubility in water
(maximum solubility of 1,100 ppm), a great
deal of TCE has contaminated groundwater
in aquifers and wells, often extending up to
10 km from its original dumping source (28).
TCE and other chlorinated hydrocarbons are
relatively stable in pure water at a pH of 7
and have extremely long half-lives unless
degraded by chlorine removal, hydrolysis, and
subsequent aerobic metabolism (28). The
highest concentration chosen for this study
was the maximum solubility of TCE. The
next level was selected at a factor of 1,000
less. This was initially chosen to determine if
this low-level dose would elicit a response in
the rat model. When results from these two
levels demonstrated a cardiac teratogenic
potential in the rat model, we decided to test
a level similar to that found in the Tucson
basin’s highest contamination area, 250 ppb.
A concentration of 100-fold less was chosen
to provide a very low exposure to TCE in
drinking water and to attempt to establish a
dose relationship.
There is a 35% reduction in the concen-
tration of TCE over a 24-hr period in our
study. Therefore, the amounts received by the
rats per day (reported as either concentration
or dose) were calculated by the average of the
breakdown over a 24-hr period and the aver-
age amount of drinking water consumed by
each group. The levels are given in Table 1.
For consistency and ease of reporting, we
refer to the levels by the initial concentration.
Even the lowest concentration of 2.5 ppb
TCE received by the rats is at least four times
as high as the average received by humans in
drinking water alone in the epidemiology
studies, and direct extrapolation cannot be
made. The recommended ambient water con-
centration for TCE is 27 ppb—that is, a fac-
tor of 10 lower than the level at which this
study demonstrated a trend toward higher
incidence of heart defects in fetuses (29).
Given that humans also have additional
sources of uptake (e.g., respiratory), the evi-
dence of an overall dose–effect response and a
possible threshold level at less than 250 ppb,
as shown in this study, should indicate the
importance of restricting contamination by
this compound to the lowest possible level.
Care must always be taken in extrapolat-
ing rodent experimental data to humans. As
suggested by other researchers in this field,
instead of a straight-line extrapolation model,
a threshold model (from high doses in
rodents to low doses in humans) may be
more appropriate (30). The concentration of
TCE range used in this study is large, and
dose increases in smaller increments would
further delineate the threshold or dose
response to TCE. It would be of interest to
look closer at the lower concentration levels
and use larger numbers of animals to improve
statistical signiﬁcance.
Conclusion
In summary, we present further evidence that
drinking water contaminated by TCE is asso-
ciated with increased incidence of congenital
cardiac malformations. This study confirms
our previous studies regarding the cardiac ter-
atogenesis, but not general teratogenesis, of
TCE when administered in drinking water.
The data from Boyer et al. (24) suggest that
the cardiac valvular and septal malformations
may be caused by TCE inhibiting endothelial
separation and early events of mesenchymal
cell formation in the developing heart.
Moreover, the data from this study reveal a
threshold level of less than 250 ppb TCE
above which rats exposed to increasing levels
of TCE during pregnancy have increasing
incidences of cardiac malformations in their
fetuses. This information reinforces the impor-
tance of adhering to ambient levels of TCE
recommended by the U.S. Environmental
Protection Agency, which will help to mini-
mize the potential health risks associated with
these chemicals.
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Figure 1. Dose–response pattern for treated and
control groups. 
*Compared to control, p = 0.14; **compared to control, p =
0.04; #compared to control, p < 0.001.
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Figure 2. Dose–response pattern for treated and
control litters. 
*Compared to control, p = 0.08; **compared to control, p =
0.05; #compared to control, p < 0.001. 
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Figure 3. Results of probit analysis.
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